BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4710286)

  • 1. [Use of DDAVP in children's diabetes insipidus].
    Raska B; Straková M; Holecek V
    Cesk Pediatr; 1973; 28(5):262-4. PubMed ID: 4710286
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin) in the treatment of diabetes insipidus in children.
    Némethová V; Lichardus B
    Endokrinologie; 1974 Mar; 63(1):137-41. PubMed ID: 4611759
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nephrogenic diabetes insipidus. Response to DDAVP and genetic transmission in 2 family groups].
    Bernasconi S; Savi M; Giovannelli G
    Minerva Nefrol; 1976; 23(3):208-12. PubMed ID: 1018863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Familial primary vasopressin resistant diabetes insipidus sensitive to biguanide].
    Villamor J; Hita J; Barreiro P; Ortiz Vázquez J; Vãzquez JJ
    Rev Clin Esp; 1971 Apr; 121(1):51-62. PubMed ID: 5563103
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of a vasopressin analog, DDAVP, in 4 patients with diabetes insipidus].
    Borner W; Froesch ER
    Schweiz Med Wochenschr; 1974 Apr; 104(16):579-82. PubMed ID: 4827026
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of diabetes insipidus with I-deamino-8-D-arginine-vasopressin].
    Czakó L; László F
    Orv Hetil; 1975 May; 116(20):1153-7. PubMed ID: 1134788
    [No Abstract]   [Full Text] [Related]  

  • 7. [Familial diabetes insipidus of central origin (author's transl)].
    Bruguier A; Poisson D; Lestradet H; Labrune B
    Nouv Presse Med; 1981 Mar; 10(11):897-9. PubMed ID: 7208293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of diabetes insipidus with a synthetic arginine-vasopressin analog].
    Oravec D; Lichardus B; Kovác R; Sárkady H; Zaoral M
    Z Gesamte Inn Med; 1972 Nov; 27(22):993-4. PubMed ID: 4649662
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (author's transl)].
    Irmscher K; Sennejunker K; Wiegelmann W; Solbach HG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2431-7. PubMed ID: 4614967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Successful substitution therapy of diabetes insipidus centralis in the Hand-Schüller-Christian type of histiocytosis X by using synthetic analogue of vasopressin--DDAVP].
    Némethová V; Sýkora F; Lichardus B
    Bratisl Lek Listy; 1974 Mar; 61(3):366-71. PubMed ID: 4825136
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapy of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (autor's transl)].
    Novotný P
    Cas Lek Cesk; 1973 Jul; 112(35):1083-4. PubMed ID: 4751289
    [No Abstract]   [Full Text] [Related]  

  • 12. [Occult diabetes insipidus of a pitressin-resistant and familial type in infants. Presentation of a case].
    Gandullia E; Lignana E
    Minerva Pediatr; 1979 Mar; 31(6):429-34. PubMed ID: 470886
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of adiuretin-SD (DDAVP) and pitressin tannate in diabetes insipidus].
    László C; János J; Ferenc L
    Orv Hetil; 1977 Jul; 118(28):1648-50. PubMed ID: 876650
    [No Abstract]   [Full Text] [Related]  

  • 14. DDAVP in treatment of vasopressin-sensitive diabetes insipidus.
    Ward MK; Fraser TR
    Br Med J; 1974 Jul; 3(5923):86-9. PubMed ID: 4851464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: A synthetic analog of vasopressin (DDAVP). Value in the treatment of pitressin-sensitive diabetes insipidus].
    Toursel F; Fontaine G
    Nouv Presse Med; 1975 Jan; 4(3):190. PubMed ID: 1093122
    [No Abstract]   [Full Text] [Related]  

  • 18. A vasopressin analogue in treatment of diabetes insipidus.
    Kauli R; Laron Z
    Arch Dis Child; 1974 Jun; 49(6):482-5. PubMed ID: 4850356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug information. New drug. New vasopressin analog in the treatment of diabetes insipidus].
    Buch-Andreasen P
    Ugeskr Laeger; 1974 Nov; 136(47):2626. PubMed ID: 4446089
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of 1-desamino-8-D-arginine vasopressin (DDAVP) in the management of neurogenic diabetes insipidus (multiple etiologies in pediatric patients).
    Brown DR; Uden DL
    Minn Med; 1979 Jun; 62(6):427-32. PubMed ID: 492086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.